Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 52,251 | 31,799 | 36,942 | 54,292 | 23,413 |
| Marketable Securities | 71,017 | 59,035 | 87,675 | 72,060 | 107,146 |
| Receivables | 1,312 | 1,204 | 1,431 | 742 | 566 |
| Other current assets | 0 | 0 | 0 | 128 | 128 |
| TOTAL | $127,704 | $93,828 | $129,229 | $129,366 | $132,564 |
| Non-Current Assets | |||||
| PPE Net | 6,927 | 8,676 | 10,145 | 12,183 | 6,945 |
| Investments And Advances | 0 | 0 | 22,224 | 12,601 | 12,601 |
| Intangibles | 0 | 0 | 66,307 | 83,011 | 123,809 |
| Other Non-Current Assets | 2,449 | 3,031 | 0 | 0 | 0 |
| TOTAL | $9,376 | $11,707 | $98,676 | $107,795 | $143,355 |
| Total Assets | $137,080 | $105,535 | $227,905 | $237,161 | $275,919 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,151 | 7,235 | 9,429 | 10,646 | 9,910 |
| Other current liabilities | N/A | N/A | 1,331 | N/A | 107 |
| TOTAL | $9,541 | $7,828 | $11,239 | $14,627 | $10,585 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 12,001 | 12,001 |
| Deferred Revenues | N/A | N/A | N/A | 2,742 | 15 |
| Other Non-Current Liabilities | 25,573 | 24,963 | 3,126 | 10,424 | 9,065 |
| TOTAL | $25,573 | $24,963 | $16,432 | $40,061 | $62,329 |
| Total Liabilities | $35,114 | $32,791 | $27,671 | $54,688 | $72,914 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 95,584 | N/A | N/A | 55,070 | 55,023 |
| Common Shares | 985,939 | 898,535 | 879,405 | 876,108 | 867,393 |
| Retained earnings | -1,045,961 | -970,093 | -805,221 | -738,070 | -652,746 |
| Other shareholders' equity | -48,171 | -48,229 | -48,170 | -48,185 | -48,185 |
| TOTAL | $101,966 | $72,744 | $200,234 | $182,473 | $203,005 |
| Total Liabilities And Equity | $137,080 | $105,535 | $227,905 | $237,161 | $275,919 |